ArticleThe Journal of clinical investigation2023

Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab.

Xuan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.